Abstract
Background
The MNS16A polymorphism is located in the downstream region of the hTERT gene and affects telomerase activity.
Methods
MNS16A has been investigated as a potential risk factor and/or prognostic marker for malignant glioma in a cohort of 352 patients (205 glioblastoma, 147 anaplastic gliomas) and 305 controls.
Results
The S (“short”) allele (which results in a higher telomerase activity) was significantly more frequent in glioma patients compared to the control population (278/704 = 39.5% vs. 200/610 = 32.8%; P = 0.012). The odd ratios were 1 for LL (taken as reference), 1.33 [0.96; 1.84] for SL and 2.05 [1.22; 3.44] for SS. However, in contrast to a previous report, no significant difference of survival was found between SS, LL and SL allelotypes.
Conclusion
We found here the short allele of MNS16A more frequent in glioma patients, but it did not seem to be predictive of survival.

Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Sanson M, Thillet J, Hoang-Xuan K (2004) Molecular changes in gliomas. Curr Opin Oncol 16:607–613
Falchetti ML, Larocca LM, Pallini R (2002) Telomerase in brain tumors. Childs Nerv Syst 18:112–117
Wang L, Soria JC, Chang YS, Lee HY, Wei Q, Mao L (2003) Association of a functional tandem repeats in the downstream of human telomerase gene and lung cancer. Oncogene 22:7123–7129
Wang L, Wei Q, Wang LE, Aldape KD, Cao Y, Okcu MF, Hess KR, El-Zein R, Gilbert MR, Woo SY, Prabhu SS, Fuller GN, Bondy ML (2006) Survival prediction in patients with glioblastoma multiforme by human telomerase genetic variation. J Clin Oncol 24:1627–1632
Tchirkov A, Rolhion C, Kemeny JL, Irthum B, Puget S, Khalil T, Chinot O, Kwiatkowski F, Perissel B, Vago P, Verrelle P (2003) Clinical implications of quantitative real-time RT-PCR analysis of hTERT gene expression in human gliomas. Br J Cancer 88:516–520
Acknowledgements
This work was supported by the grants from the Institut National du Cancer (PL 046), the Délégation à la Recherche Clinique (AP-HP; grant n° MUL 03012) and the Ligue Nationale contre le Cancer, comité d’Ile et Villaine. The authors gratefully thank Anne-Marie Lekieffre, Muriel Brandel, Marc Ouzounian and Tristan Salmon-Legagneur from the ARTC for their precious assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Carpentier, C., Lejeune, J., Gros, F. et al. Association of telomerase gene hTERT polymorphism and malignant gliomas. J Neurooncol 84, 249–253 (2007). https://doi.org/10.1007/s11060-007-9378-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-007-9378-3